|
Market Closed -
NYSE
21:00:00 17/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.060 USD | -0.93% |
|
-3.64% | -36.53% |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
NYSE
LCTX 1.060 $
-0.93%
842K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| LCTX | 1.060USD | -0.93% | 842K $ | |
CBOE
| LCTX | 1.065USD | -0.93% | 25.67K $ | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | 325.90ILa | -0.91% | 444K ILa | |
|
Tradegate
| BT3 | 0.9200EUR | -1.08% | 11.96 € | |
|
Deutsche Boerse AG
| BT3 | 0.8940EUR | +0.45% | 0 € | |
|
Börse Stuttgart
| BT3 | 0.9040EUR | -0.99% | 0 € | |
|
Boerse Muenchen
| BT3 | 0.9360EUR | 0.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.2 | 1.35 | 1.35 |
| Spread/Res. | -11.67% | -21.48% | -21.48% |
| Spread/Supp. | +2.91% | +2.91% | +2.91% |
| Support | 1.03 | 1.03 | 1.03 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
